Inhibition of monoamine oxidase in 5‐ hydroxytryptaminergic neurones by substituted p‐aminophenylalkylamines
Open Access
- 19 July 1985
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 85 (3), 683-690
- https://doi.org/10.1111/j.1476-5381.1985.tb10564.x
Abstract
1 A series of substituted p-aminophenethylamines and some related compounds were examined with regards to the inhibition of monoamine oxidase (MAO) in vivo inside and outside 5-hydroxytryptaminergic neurones in the rat hypothalamus. This was recorded as the protection against the irreversible inhibition of MAO produced by phenelzine by determining the remaining deaminating activity in the absence and presence of citalopram using a low (0.1 μM) concentration of [14C]-5-hydroxytryptamine (5-HT) as substrate. 2 Some of the phenethylamines were much more potent inside than outside the 5-hydroxytryptaminergic neurones. This neuronal selectivity was antagonized by pretreatment of the rats with norzimeldine, a 5-HT uptake inhibitor, which indicates that these compounds are accumulated in the 5-HT nerve terminals by the 5-HT pump. 3 Selectivity was obtained for compounds with dimethyl, monomethyl or unsubstituted p-amino groups. An isopropyl group appears to substitute for the dimethylamino group but with considerably lower potency. Compounds with 2-substitution showed selectivity for aminergic neurones and this effect decreased with increased size of the substituent. The 2,6-dichloro derivative FLA 365 had, however, no neuronal selective action but was a potent MAO inhibitor. Substitutions in the 3- and 5- positions decreased both potency and selectivity. 4 Prolongation of the side chain with one methylene group abolished the preference for the MAO in 5-hydroxytryptaminergic neurones although the MAO inhibitory potency remained. The selectivity disappeared by increasing the α-substituent to an ethyl group but remained for the α,α-dimethyl substituted derivatives. 5 It is concluded that compounds which are (1) transported by the 5-HT pump and (2) potent reversible MAO-A inhibitors produce pronounced inhibition of MAO in 5-hydroxytryptaminergic neurones.This publication has 10 references indexed in Scilit:
- Intra- and Extraneuronal Monoamine OxidaseJournal of Vascular Research, 1984
- Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- Evidence for a Selective Inhibition by FLA 336(+) of the Monoamine Oxidase in Serotonergic Neurones in the Rat BrainActa Pharmacologica et Toxicologica, 1982
- (+)-4-dimethylamino-2, α-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the a form of monoamine oxidase in the rat brainBiochemical Pharmacology, 1982
- Selective inhibition of the a form of monoamine oxidase by 4-dimethylamino-α-methylphenylalkylamine derivatives in the ratNeuropharmacology, 1982
- Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activityProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Substrate- and stereoselective inhibition of human brain monoamine oxidase by 4-dimethylamino-α, 2-dimethylphenethylamine (FLA 336)Journal of Pharmacy and Pharmacology, 1981
- A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)- amphetamine, p-methoxy amphetamine and harmalineBiochemical Pharmacology, 1980
- Structural Requirements for Uptake into Serotoninergic NeuronesActa Pharmacologica et Toxicologica, 1980
- Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamineJournal of Medicinal Chemistry, 1978